Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortium.
Heinzl N, Maritschnegg E, Koziel K, Schilhart-Wallisch C, Heinze G, Yang WL, Bast RC, Sehouli J, Braicu EI, Vergote I, Van Gorp T, Mahner S, Paspalj V, Grimm C, Obermayr E, Schuster E, Holzer B, Rousseau F, Schymkowitz J, Concin N, Zeillinger R.
Heinzl N, et al. Among authors: koziel k.
Oncogene. 2023 Aug;42(33):2473-2484. doi: 10.1038/s41388-023-02758-8. Epub 2023 Jul 4.
Oncogene. 2023.
PMID: 37402882